Joseph Quintana
Cardiovascular Disease · Santa Teresa, NMNPI 1477553196
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,843 of the $10,627 with a category attached, or 73.8%. It is spread thinly across 40 manufacturers, the largest accounting for just 14.9%. Reporting peaked in 2019 at $3,142 and has fallen 91.2% since, to $276 in 2025.
Across 256 payments — averaging $41.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Abbott$1K
- Abiomed$1K
- Boston Scientific$1K
- Bard Peripheral Vascular, Inc.$1K
- Medtronic$585
- plus $3K from 34 others
What the payments were for
- Travel & lodging$2,75826%
- Food & beverage$7,84374%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 7 | $1,584 |
| Abbott | 26 | $1,489 |
| Abiomed | 35 | $1,432 |
| Boston Scientific | 7 | $1,419 |
| Bard Peripheral Vascular, Inc. | 9 | $1,181 |
| Medtronic(2 entities) | 18 | $585 |
| Novartis | 26 | $325 |
| Johnson & Johnson | 17 | $274 |
| Asahi Intecc USA, Inc. | 4 | $224 |
| AbbVie(2 entities) | 14 | $202 |
| Boehringer Ingelheim | 13 | $195 |
| Angiodynamics, Inc. | 2 | $194 |
| AstraZeneca | 10 | $177 |
| Amgen | 9 | $162 |
| Nevro Corp. | 1 | $122 |
| Merck | 7 | $111 |
| Philips North America LLC | 3 | $108 |
| E.r. Squibb & Sons, L.L.C. | 6 | $93 |
| Impulse Dynamics (USA) Inc. | 1 | $78 |
| Amarin Pharma, Inc. | 4 | $74 |
| Sanofi-aventis U.S. LLC | 3 | $71 |
| Pfizer | 5 | $65 |
| Biocompatibles, Inc. | 4 | $53 |
| Cardiovascular Systems Inc. | 2 | $45 |
| Tactile Systems Technology Inc | 3 | $42 |
| Gilead | 3 | $41 |
| Novo Nordisk | 2 | $32 |
| Bayer | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Chiesi USA, Inc. | 2 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $24 |
| Convatec Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| Sanofi | 1 | $17 |
| Inari Medical, Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Vifor Pharma, Inc. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Varithena Administration Pack$1,378
- Indigo$1,210
- VENOVO$1,062
- Quadra Assura CRT Defibrillator$287
- AlphaVac$173
- Impella$138
- Quartet CRT Lead$137
- Confirm Rx$132
- Senza$122
- Tendril Pacing Lead$119
- Penumbra System$118
- XARELTO$115
- Allure Quadra RF CRT Pacemaker$114
- Indigo System$103
How this compares
$10,627 in reported general payments places this provider in the 85th percentile of 101 cardiovascular disease providers in New Mexico.
Other cardiovascular disease in Santa Teresa
- Abinash AchrekarAlbuquerque$88K
- Suresh NeelagaruChama$46K
- Adam BanksAlbuquerque$38K
- Jose Rodriguez ArciniegaLas Cruces$24K
- Stacey CleggAlbuquerque$21K
- Leonardo MaciasAlbuquerque$15K
- William RobinsonFarmington$14K
- Muhammad AnwarLas Cruces$14K
- Carolina Ponce OrellanaAlbuquerque$12K
- Robert GraorLas Cruces$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.